HIMS HERS HEALTH INC

NYSE: HIMS (Hims & Hers Health, Inc.)

Last update: 06 Apr, 10:39AM

20.06

0.91 (4.78%)

Previous Close 19.14
Open 19.78
Volume 8,101,979
Avg. Volume (3M) 34,930,563
Market Cap 4,571,312,128
Price / Earnings (TTM) 39.32
Price / Earnings (Forward) 45.66
Price / Sales 2.14
Price / Book 8.19
52 Weeks Range
13.74 (-31%) — 70.43 (251%)
Earnings Date 4 May 2026
Profit Margin 9.21%
Operating Margin (TTM) 10.12%
Diluted EPS (TTM) 0.680
Quarterly Revenue Growth (YOY) 110.70%
Quarterly Earnings Growth (YOY) 344.70%
Total Debt/Equity (MRQ) 11.54%
Current Ratio (MRQ) 1.59
Operating Cash Flow (TTM) 334.34 M
Levered Free Cash Flow (TTM) 213.45 M
Return on Assets (TTM) 10.76%
Return on Equity (TTM) 36.79%

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - Specialty & Generic (US) Mixed Bullish
Drug Manufacturers - Specialty & Generic (Global) Mixed Bullish
Stock Hims & Hers Health, Inc. Bearish Bearish

AIStockmoo Score

1.1
Analyst Consensus -0.5
Insider Activity -1.5
Price Volatility 4.5
Technical Moving Averages 3.5
Technical Oscillators -0.5
Average 1.10

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
HIMS 5 B - 39.32 8.19
TAK 56 B 4.61% 81.00 1.19
HLN 44 B 1.17% 20.35 1.98
RDY 11 B 54.73% 17.99 2.75
TEVA 37 B - 25.74 4.59
ZTS 51 B 0.42% 19.95 14.95

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Investment Style Small Growth
% Held by Insiders 11.13%
% Held by Institutions 82.47%
52 Weeks Range
13.74 (-31%) — 70.43 (251%)
Price Target Range
17.00 (-15%) — 60.00 (199%)
High 60.00 (BTIG, 199.18%) Buy
Median 24.00 (19.67%)
Low 17.00 (TD Cowen, -15.23%) Hold
Average 26.50 (32.14%)
Total 3 Buy, 8 Hold
Avg. Price @ Call 20.23
Firm Date Target Price Call Price @ Call
Barclays 11 Mar 2026 29.00 (44.60%) Buy 25.88
25 Feb 2026 25.00 (24.66%) Buy 15.82
B of A Securities 10 Mar 2026 23.00 (14.68%) Hold 23.47
09 Feb 2026 21.00 (4.71%) Sell 19.33
Citigroup 10 Mar 2026 24.00 (19.67%) Hold 23.47
24 Feb 2026 13.25 (-33.93%) Sell 15.46
Deutsche Bank 10 Mar 2026 28.00 (39.62%) Hold 23.47
Needham 09 Mar 2026 30.00 (49.59%) Buy 22.16
Morgan Stanley 25 Feb 2026 21.00 (4.71%) Hold 15.82
Evercore ISI Group 24 Feb 2026 24.00 (19.67%) Hold 15.46
Leerink Partners 24 Feb 2026 17.50 (-12.74%) Hold 15.46
TD Cowen 24 Feb 2026 17.00 (-15.23%) Hold 15.46
09 Feb 2026 20.00 (-0.27%) Hold 19.33
Truist Securities 24 Feb 2026 18.00 (-10.25%) Hold 15.46
BTIG 02 Feb 2026 60.00 (199.18%) Buy 26.44
Show more
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
OKUPE OLUYEMI - 20.33 -3,975 -80,812
Aggregate Net Quantity -3,975
Aggregate Net Value ($) -80,812
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 20.33
Name Holder Date Type Quantity Price Value ($)
OKUPE OLUYEMI Officer 06 Apr 2026 Automatic sell (-) 3,975 20.33 80,812
OKUPE OLUYEMI Officer 06 Apr 2026 Option execute 3,975 - -

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria